Clinical trial

Flavopiridol in Treating Patients With Refractory Cancer

NCT00019344

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1997-08-01

PhasePHASE1

Study timeline

Study start (unknown)1997-08-01Date precision: month

Registry last updated2015-04-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lymphomaunresolved

Prostate Cancerunresolved

Small Intestine Cancerunresolved

Unspecified Adult Solid Tumor, Protocol Specificunresolved

Interventions

alvocidibDRUG

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Mapped research locations

BethesdaMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00019344 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.